Pharmaceutical delivery regulation: the logistics bottleneck impacting the retail pharmacy sector

Anvisa’s decision to defer regulatory authority over app-based medication delivery to the National Congress marks a turning point for the Brazilian digital retail expansion strategy. In a market where the 12-month IPCA reached 4.44%, last-mile logistics efficiency has become the determining variable for the sustainability of operating margins for major pharmacy chains. This move, which halts expectations for a unified technical standard, introduces a layer of legal uncertainty that consumer sector investors must monitor closely, as legislative fragmentation could significantly increase operating costs. Current macroeconomic conditions, including a commercial dollar rate of R$ 5.1714 with a 1.47% rise over the last 7 days, are pressuring pharmaceutical import costs. Amid this volatile environment, SG&A cost control remains the key metric for assessing the financial health of listed companies. If regulation becomes restrictive, logistics costs for platforms could rise by up to 15%, squeezing e-commerce profitability.